Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control

L Rejnmark1, P Vestergaard, L Mosekilde

  • 1Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus Sygehus, Tage Hansens Gade 2, 8000, Aarhus C, Denmark. rejnmark@post6.tele.dk

Insights

Elderly patients with atrial fibrillation or treated with amiodarone face higher fracture risks. However, digoxin use may decrease fracture risk, especially with higher doses.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Pharmacology

Background:

  • Cardiac arrhythmias and osteoporotic fractures are prevalent health concerns in the elderly population.
  • Understanding the interplay between these conditions and their treatments is crucial for geriatric care.

Purpose of the Study:

  • To investigate the association between tachyarrhythmia, antiarrhythmic drug use, and the risk of osteoporotic fractures.
  • To identify specific arrhythmias and medications that influence fracture risk in older adults.

Main Methods:

  • A nationwide, population-based, pharmaco-epidemiological case-control study was conducted.
  • 124,655 fracture patients were compared with 373,962 age- and gender-matched controls using computerized registers for drug use and fracture data.
  • Confounding factors were assessed and adjusted for in the analysis.

Main Results:

  • Atrial fibrillation was associated with an increased risk of any fracture (OR: 1.14).
  • Treatment with amiodarone significantly increased fracture risk (OR: 1.47), while digoxin use decreased it (OR: 0.75).
  • Digoxin's protective effect on fracture risk was dose-dependent and observed in individuals over 65.

Conclusions:

  • Patients with atrial fibrillation or on amiodarone treatment require careful monitoring for fracture risk.
  • Digoxin therapy may offer a protective benefit against osteoporotic fractures in the elderly.
  • Further research into the mechanisms underlying these associations is warranted.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...